A synthesis of clinical evidence on chronic pain, pediatric epilepsy, psychiatric conditions, and real-world evidence registries Introduction The legalization of medicinal cannabis in Australia in 2016 initiated a rapid transformation in patient access and clinical practice. By June 2022, the Therapeutic Goods Administration (TGA) had recorded 258,926 prescription approvals under the Special Access Scheme Category […]









